Startup ASEAN

PRESTIGE BIOPHARMA LIMITED

View Website

Related Keywords

ACTIVE Healthcare & Education Biotechnology

Headquarter Location

NUCLEOS 21 BIOPOLIS ROAD #04-24/28 Singapore 138567

Company Profile Prestige BioPharma (PBP) is a Singapore based biopharmaceutical company specializing in the discovery and development of innovative biologics and biosimilars. The company's Herceptin Biosimilar, HD201, is currently projected to launch in the 2019 market, and is rapidly growing as a leading global biopharmaceutical company. Based on the cutting-edge technologies and GMP manufacturing facilities, the company's current biosimilar pipeline includes: Herceptin Biosimilar (HD201), Avastin Biosimilar (HD204), Humira Adalimumab (PBP1502), Remicade Biosimilar (PBP1505), Rituxan Biosimilar (PBP1506), and Enbrel Biosimilar (PBP1507). The primary focus of current PBP’s R&D is oncology and immune disorders, developing new and similar antibody drugs for solid tumor, pancreatic cancer, and arthritis. In parallel with our efforts to enhance safety, efficacy, and affordability of existing antibody therapeutics, PBP thrives to search for new targets and candidates with a goal to free mankind from devastating diseases Established on core values cherishing life and fostering the spirit of philanthropy, Prestige BioPharma promises to grow everyday to make our dream come true.

Overview

Website

https://http://www.prestigebiopharma.com/

info@pbpsg.com

Founded Date

2014-01-13

Company Size

Company Stage

Industry

Healthcare & Education

Technology

Biotechnology

Client Focus

Status

ACTIVE

Headquarter Location

NUCLEOS 21 BIOPOLIS ROAD #04-24/28 Singapore 138567